A phase I study of oral CC-5013 (lenalidomide, Revlimid), a thalidomide derivative, in patients with refractory metastatic cancer (Q44836113)
Jump to navigation
Jump to search
scientific article published in March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of oral CC-5013 (lenalidomide, Revlimid), a thalidomide derivative, in patients with refractory metastatic cancer |
scientific article published in March 2004 |
Statements
1 reference
A phase I study of oral CC-5013 (lenalidomide, Revlimid), a thalidomide derivative, in patients with refractory metastatic cancer (English)
1 reference
James L Gulley
1 reference
Tanyifor M Tohnya
1 reference
Sylvia S W Ng
1 reference
William L Dahut
1 reference
John J Wright
1 reference
Philip M Arlen
1 reference
Catherine Parker
1 reference
Jerome Zeldis
1 reference
William D Figg
1 reference
1 March 2004
1 reference
1 reference
Identifiers
1 reference